Ashley Zehnder, the founder and CEO of Fauna Bio, dives into the fascinating world of hibernation and its secrets for human health. She discusses how the genomic data from hibernating animals can unlock potential treatments for obesity, heart attacks, and more. With her company's use of AI, they're identifying gene-disease links that could lead to groundbreaking drug therapies. The partnership with Eli Lilly highlights the innovative strategies being used in drug discovery, particularly in tackling obesity and enhancing our understanding of tissue regeneration.